Literature DB >> 9399917

PTEN: sometimes taking it off can be better than putting it on.

M P Myers, N K Tonks.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9399917      PMCID： PMC1716096          DOI： 10.1086/301659

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN： 0002-9297            Impact factor:   11.025


× No keyword cloud information.
  30 in total

1.  P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase.

Authors:  M P Myers; J P Stolarov; C Eng; J Li; S I Wang; M H Wigler; R Parsons; N K Tonks
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

2.  Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease.

Authors:  M R Nelen; W C van Staveren; E A Peeters; M B Hassel; R J Gorlin; H Hamm; C F Lindboe; J P Fryns; R H Sijmons; D G Woods; E C Mariman; G W Padberg; H Kremer
Journal:  Hum Mol Genet       Date:  1997-08       Impact factor: 6.150

3.  Germline mutations in PTEN are present in Bannayan-Zonana syndrome.

Authors:  D J Marsh; P L Dahia; Z Zheng; D Liaw; R Parsons; R J Gorlin; C Eng
Journal:  Nat Genet       Date:  1997-08       Impact factor: 38.330

4.  An RNA 5'-triphosphatase related to the protein tyrosine phosphatases.

Authors:  T Takagi; C R Moore; F Diehn; S Buratowski
Journal:  Cell       Date:  1997-06-13       Impact factor: 41.582

5.  Differential effects of diabetes on adipocyte and liver phosphotyrosine and phosphoserine phosphatase activities.

Authors:  N Begum; K E Sussman; B Draznin
Journal:  Diabetes       Date:  1991-12       Impact factor: 9.461

6.  Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies.

Authors:  H Tashiro; M S Blazes; R Wu; K R Cho; S Bose; S I Wang; J Li; R Parsons; L H Ellenson
Journal:  Cancer Res       Date:  1997-09-15       Impact factor: 12.701

7.  Transformation of cells by an inhibitor of phosphatases acting on phosphotyrosine in proteins.

Authors:  J K Klarlund
Journal:  Cell       Date:  1985-07       Impact factor: 41.582

8.  Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome.

Authors:  D Liaw; D J Marsh; J Li; P L Dahia; S I Wang; Z Zheng; S Bose; K M Call; H C Tsou; M Peacocke; C Eng; R Parsons
Journal:  Nat Genet       Date:  1997-05       Impact factor: 38.330

9.  Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers.

Authors:  P A Steck; M A Pershouse; S A Jasser; W K Yung; H Lin; A H Ligon; L A Langford; M L Baumgard; T Hattier; T Davis; C Frye; R Hu; B Swedlund; D H Teng; S V Tavtigian
Journal:  Nat Genet       Date:  1997-04       Impact factor: 38.330

10.  Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas.

Authors:  E Rhei; L Kang; F Bogomolniy; M G Federici; P I Borgen; J Boyd
Journal:  Cancer Res       Date:  1997-09-01       Impact factor: 12.701
View more
  19 in total

Review 1.  Gonadoblastoma, testicular and prostate cancers, and the TSPY gene.

Authors:  Y F Lau
Journal:  Am J Hum Genet       Date:  1999-04       Impact factor: 11.025

2.  PTEN controls tumor-induced angiogenesis.

Authors:  S Wen; J Stolarov; M P Myers; J D Su; M H Wigler; N K Tonks; D L Durden
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

Review 3.  Genetic alterations of PTEN in human melanoma.

Authors:  Almass-Houd Aguissa-Touré; Gang Li
Journal:  Cell Mol Life Sci       Date:  2011-11-11       Impact factor: 9.261

4.  Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway.

Authors:  S Ramaswamy; N Nakamura; F Vazquez; D B Batt; S Perera; T M Roberts; W R Sellers
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

5.  Drosophila tumor suppressor PTEN controls cell size and number by antagonizing the Chico/PI3-kinase signaling pathway.

Authors:  D C Goberdhan; N Paricio; E C Goodman; M Mlodzik; C Wilson
Journal:  Genes Dev       Date:  1999-12-15       Impact factor: 11.361

Review 6.  New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway.

Authors:  L C Cantley; B G Neel
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

Review 7.  Rationale-based therapeutic combinations with PI3K inhibitors in cancer treatment.

Authors:  Pau Castel; Eneda Toska; Zachary S Zumsteg; F Javier Carmona; Moshe Elkabets; Ana Bosch; Maurizio Scaltriti
Journal:  Mol Cell Oncol       Date:  2014-10-29

8.  Transcriptional activation of p21WAF1 by PTEN/MMAC1 tumor suppressor.

Authors:  R C Wu; X Li; A H Schönthal
Journal:  Mol Cell Biochem       Date:  2000-01       Impact factor: 3.396

9.  The lipid phosphatase activity of PTEN is critical for its tumor supressor function.

Authors:  M P Myers; I Pass; I H Batty; J Van der Kaay; J P Stolarov; B A Hemmings; M H Wigler; C P Downes; N K Tonks
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

10.  A novel germline mutation of PTEN associated with brain tumours of multiple lineages.

Authors:  F J T Staal; R B van der Luijt; M R M Baert; J van Drunen; H van Bakel; E Peters; I de Valk; H K P van Amstel; M J B Taphoorn; G H Jansen; C W M van Veelen; B Burgering; G E J Staal
Journal:  Br J Cancer       Date:  2002-05-20       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.